A method of inhibiting angiogenesis in mammals using introduction of an 18 amino acid tandem-repeat dimer peptide of apolipoprotein E residues 141-149 into the mammal, in an amount effective to inhibit angiogenesis in the mammal compared to the rate of angiogenesis which would occur in the mammal in the absence of the apolipoprotein E dimer peptide.
